Insights from 2024 EHA Annual Meeting
Video Player is loading.
10 seconds
Playback speed
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
By
Insights from 2024 EHA Annual Meeting
FEATURING
Wojciech Jurczak
By
Insights from 2024 EHA Annual Meeting
FEATURING
Wojciech Jurczak
Comments 0
Login to view comments.
Click here to Login
